Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP334052.RALq9a3ivLRXA9e80oEFFgwftugRuUCuphTTessPt4G3w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP334052.RALq9a3ivLRXA9e80oEFFgwftugRuUCuphTTessPt4G3w130_assertion type Assertion NP334052.RALq9a3ivLRXA9e80oEFFgwftugRuUCuphTTessPt4G3w130_head.
- NP334052.RALq9a3ivLRXA9e80oEFFgwftugRuUCuphTTessPt4G3w130_assertion description "[Heterozygous mutations in the human transcription factor gene NKX2.5 are associated with either isolated or combined congenital heart disease (CHD), primarily secundum atrial septal defect-II (ASD-II), ventricular septal defect (VSD) or tetralogy of Fallot (TOF).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP334052.RALq9a3ivLRXA9e80oEFFgwftugRuUCuphTTessPt4G3w130_provenance.
- NP334052.RALq9a3ivLRXA9e80oEFFgwftugRuUCuphTTessPt4G3w130_assertion evidence source_evidence_literature NP334052.RALq9a3ivLRXA9e80oEFFgwftugRuUCuphTTessPt4G3w130_provenance.
- NP334052.RALq9a3ivLRXA9e80oEFFgwftugRuUCuphTTessPt4G3w130_assertion SIO_000772 20456451 NP334052.RALq9a3ivLRXA9e80oEFFgwftugRuUCuphTTessPt4G3w130_provenance.
- NP334052.RALq9a3ivLRXA9e80oEFFgwftugRuUCuphTTessPt4G3w130_assertion wasDerivedFrom befree-20150227 NP334052.RALq9a3ivLRXA9e80oEFFgwftugRuUCuphTTessPt4G3w130_provenance.
- NP334052.RALq9a3ivLRXA9e80oEFFgwftugRuUCuphTTessPt4G3w130_assertion wasGeneratedBy ECO_0000203 NP334052.RALq9a3ivLRXA9e80oEFFgwftugRuUCuphTTessPt4G3w130_provenance.